CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
    Peptide
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Antibodies
  • Top Antibodies Technology Solution In APAC

Top Antibodies Technology Solution In APAC

We’re thrilled to present the Top Antibodies Technology Solution In APAC, a prestigious honor recognizing the industry’s game-changers. These exceptional businesses were nominated by our subscribers based on impeccable reputation and the trust these companies have garnered from our valued subscribers. After an intense selection process—led by C-level executives, industry pioneers and our expert editorial team—only the best have made the cut. These companies have been selected as recipients of the award, celebrating their leadership and innovation.
Top Antibodies Technology Solution In APAC

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Antibodies Technology Solution In APAC

    ★Featured Companies
    GL BIOCHEM
    GL BIOCHEM
    Read full profile →
    GL BIOCHEM is a Shanghai-based peptide manufacturer that industrializes complex peptide science at scale, delivering reagents, custom synthesis and cGMP-grade materials. With 28 years of experience, it supplies global life sciences with ... read full profile
    ADBIOTECH
    ADBIOTECH
    Read full profile →
    ADBIOTECH is a South Korean biotech firm specializing in innovative antibody solutions for animal health. Leveraging proprietary IgY and nanobody platforms, the company develops targeted treatments that address antibiotic resistance and ... read full profile
    Adagene
    Adagene
    Adagene is a global clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer. It is driven by a powerful platform combining computational biology and artificial intelligence. It creates antibodies that overcome safety issues and improve efficacy to bring hope to more cancer patients. Its discovery engine, Dynamic Precision Library, is driving Adagene’s pipeline of programs with potential to be best in class.
    Akeso, Inc.
    Akeso, Inc.
    Akeso, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative biologic medicines. It develops best-in-class therapies including bispecific and multispecific antibodies, ADCs, mRNA and cell therapies. With a diversified pipeline covering cancer, autoimmune, inflammation, metabolic, and neurological issues, Akeso aims to address unmet medical needs globally.
    Novamab
    Novamab
    Novamab is a clinical stage biopharma company dedicated to creating life changing therapies for patients through innovative VHH technology. It is focused on developing innovative single-domain antibody drugs. Novamab develops therapies and innovates product lines targeting respiratory diseases (e.g., asthma, COPD), autoimmune disorders, and inflammatory bowel disease (IBD). It maintains a full research and development, CMC and GMP-scale production system, and holds dozens of patents positioning itself as a pioneer in nanobody drug development.
    XDC
    XDC
    XDC is a global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in antibody drug conjugates (ADCs). It provides services from discovery, chemical payload and linker synthesis, and antibody production to full GMP manufacturing of drug substances and final drug products through laboratories and manufacturing facilities, allowing for significant reduction in development timelines and costs. Its global network delivers expert-driven, high-quality, and right first time project execution for its customers.

Antibodies News

Scientific Collaboration in APAC: Advancing Lentiviral Vector Development

Thursday, October 08, 2026

Gene therapy is transforming modern medicine by opening up novel opportunities for genetic treatment of complex diseases. The development of cell and gene therapies has led to a growing need for simple and scalable viral vector platforms that are both scientifically precise and high-quality. Advances in cell and gene therapies have driven the need for simple, scalable, scientifically precise, and high-quality viral vector platforms. Lentiviral vectors are highly desirable because they can deliver genetic material to target cells and maintain expression of the transferred gene in a wide variety of therapeutic applications, among the systems available for delive

Verifiable Research Peptide Supply Across APAC

Saturday, September 19, 2026

Peptide procurement can become a research risk long before material reaches the bench. A supplier may present a convincing purity figure while leaving buyers unable to verify who manufactured the batch, whether the certificate matches the vial, how the material was handled after release or whether storage conditions were documented. For research groups working across APAC, distance compounds that uncertainty. Import timing and storage conditions can separate a nominally acceptable product from one that arrives with too many unanswered questions. Price therefore has limited meaning without evidence behind the batch. Procurement teams should be able to trace material back to a kno

The Rising Demand for Multilingual Excellence in Japan's Pharma Industry

Wednesday, April 02, 2025

Japan's pharmaceutical industry has experienced sustained growth for decades, driven by innovation and strong government support. Pharmaceutical translation services are crucial in bridging linguistic gaps and enabling global collaboration within this sector. These services ensure the precise translation of essential pharmaceutical information, supporting domestic and international operations. The Importance of Pharmaceutical Translation Services in Japan Japan is one of the largest pharmaceutical markets in the world, driven by an aging population with a growing need for innovative healthcare solutions. As the industry expands, the demand for mult

Antibody Drug Discovery: Pioneering the Future of Medicine

Tuesday, August 29, 2023

In modern medicine, the quest for innovative treatments drives scientific exploration.  FREMONT, CA: One groundbreaking area with tremendous promise is antibody drug discovery. Harnessing the power of the body's natural defense system, researchers are engineering antibodies proving to be potent and versatile tools in the fight against a wide array of diseases. Antibodies, the immune system's frontline warriors, are proteins the body produces to recognize and neutralize foreign invaders such as bacteria, viruses, and other pathogens. Inspired by nature's design, scientists are now custom-designing these

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://antibodies-apac.lifesciencesrevieweurope.com/vendors/top-antibodies-technology-solution-in-apac.html